Open AccessGranulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Author(s) -
Suresh H. Advani,
Suvarna Achreckar,
Dennis Thomas,
Binny Krishnankutty
Publication year - 2010
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/0971-5851.73590
Subject(s) - filgrastim , medicine , neutropenia , febrile neutropenia , chemotherapy , granulocyte colony stimulating factor , absolute neutrophil count , antibiotics , surgery , microbiology and biotechnology , biology
The use of granulocyte colony-stimulating factors to treat patients with chemotherapy-induced neutropenia is well accepted. To assess whether administration of filgrastim along with standard empiric antibiotic therapy is beneficial for patients with chemotherapy-induced febrile neutropenia (FN), we conducted an open, non-randomized clinical trial.